Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;142(2):689-691.e9.
doi: 10.1016/j.jaci.2018.03.011. Epub 2018 May 3.

A novel human mast cell activation test for peanut allergy

Affiliations

A novel human mast cell activation test for peanut allergy

Alexandra F Santos et al. J Allergy Clin Immunol. 2018 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
Proportion of activated LAD2 cells expressed as a percentage of CD63+ cells sensitized with plasma from children with PA, PS children, or NA children and stimulated with peanut extract (1000 ng/mL; A) or anti-IgE (1 μg/mL; B) and in relation to levels of P-sIgE (C).
Fig E1
Fig E1
A-D, Expression of FcεRI (Fig E1, A), FcγRI (Fig E1, B), FcγRII (Fig E1, C), and FcγRIII (Fig E1, D) on the surfaces of LAD2 cells. E, IgE was detectable on the surfaces of LAD2 cells after sensitization. The histogram in blue represent nonsensitized LAD2 cells, and the histogram in red represents LAD2 cells sensitized with plasma from a patient with PA. APC, Allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; PerCP, peridinin-chlorophyll-protein complex.
Fig E2
Fig E2
A, Correlation between IgE levels on the surface of LAD2 cells and total IgE levels in the plasma that the cells were sensitized with (Rs = 0.914, P < .001). B, Distribution of stimulation index (SI) IgE phycoerythrin-Cy7 in LAD2 cells sensitized with plasma from children with PA and PS children was not significantly different (P = .160).
Fig E3
Fig E3
Expression of lysosomal-associated membrane proteins (LAMPs) on the surface of LAD2 cells after stimulation with IgE-mediated and non–IgE-mediated stimulants. LAMP-1 (CD107a) and LAMP-3 (CD63) expression increases with degranulation after stimulation with peanut extract (in red), anti-IgE (in orange), or ionomycin (in blue), whereas LAMP-2 (CD107b) expression increases with degranulation with ionomycin but not IgE-mediated stimulants. The gray shaded area corresponds to the negative control (ie, unstimulated cells). APC, Allophycocyanin; FITC, fluorescein isothiocyanate; PerCP, peridinin-chlorophyll-protein complex.
Fig E4
Fig E4
Activation of LAD2 cells sensitized with plasma samples from children with PA and PS children containing similar levels of P-sIgE ranging between 0.35 and 15.0 KU/L (which correspond to the 95% negative predictive value and 95% positive predictive value determined for P-sIgE, respectively). PA, Peanut allergic; PS, peanut sensitized tolerant.
Fig E5
Fig E5
Proportion of activated mast cells sensitized with plasma samples containing varying levels of P-sIgE and Ara h 2–specific IgE. The lower limit of specific IgE above which the mast cell activation assay is reliable was estimated for peanut-specific IgE (0.4 KU/L) and for Ara h 2-specific IgE (0.2 KU/L) by observing the beginning of the inflection point from a cubic spline with a λ value of 0.8 (where the reference line intersects the smoothed regression line). PA, Peanut allergic; PS, peanut sensitized tolerant; NA, nonsensitized nonallergic.
Fig E6
Fig E6
Mast cell activation to peanut extract (1000 ng/mL) in patients with no PA (in blue at left), patients with severe allergic reactions to peanut during the OFC (in red), and patients with PA who had mild-to-moderate reactions during the OFC (in blue at right).
Fig E7
Fig E7
Receiver operating characteristic curve for the MAT to diagnose peanut allergy (A) and to identify patients at risk of severe reactions (B). The overall area under the receiver operating characteristic curve was 0.874 for Fig E7, A, and 0.934 for Fig E7, B.
Fig E8
Fig E8
Correlation between MAT results and BAT results for the same patients. Rs = 0.808 and P < .001 for the whole population and when stratified by allergic groups: 0.649, 0.066, and 0.173 for the PA, PS, and NA groups, respectively.

References

    1. Nicolaou N., Poorafshar M., Murray C., Simpson A., Winell H., Kerry G. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol. 2010;125:191–197. e1-13. - PubMed
    1. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(suppl):S1–S58. - PMC - PubMed
    1. Santos A.F., Douiri A., Becares N., Wu S.Y., Stephens A., Radulovic S. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol. 2014;134:645–652. - PMC - PubMed
    1. Mukai K., Gaudenzio N., Gupta S., Vivanco N., Bendall S.C., Maecker H.T. Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. J Allergy Clin Immunol. 2017;139:889–899.e11. - PMC - PubMed
    1. Hoffmann H.J., Santos A.F., Mayorga C., Nopp A., Eberlein B., Ferrer M. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015;70:1393–1405. - PubMed

Publication types